Rare diseases
Investigational molecules
Locations
Study of Pembrolizumab and Chemotherapy for Patients with HR+/HER2- Advanced Breast Cancer
AustriaStudy on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma
BulgariaStudy on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis
CzechiaStudy on Botulinum Toxin Type A for Preventing Episodic Migraine in Adults
CzechiaStudy on Botulinum Toxin Type A for Preventing Chronic Migraine in Adults
CzechiaStudy on the Effectiveness and Safety of SAR444656 for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on Dapagliflozin to Prevent Heart Damage in Breast Cancer Patients Receiving Anthracycline Chemotherapy
PolandStudy of GLPG3667 for Adults with Active Systemic Lupus Erythematosus
BulgariaStudy on Deucravacitinib and Apremilast for Patients with Active Psoriatic Arthritis New to Biologic Treatments or Previously on TNFα Inhibitors
BelgiumStudy on the Effects of Tigulixostat and Allopurinol in Patients with Gout and High Uric Acid Levels
BelgiumStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
CzechiaStudy on the Safety and Tolerability of TransCon IL-2 β/γ, Pembrolizumab, and Chemotherapy in Adults with Advanced or Metastatic Solid Tumors
BelgiumTell us about your condition – we search every trial in Europe and connect you with the right site.
